Form D — Ordaos, Inc.
0001933700-25-000002 · filed Apr 1, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,000,000
- Reported amount sold
- $337,705
- Minimum investment
- $24,999
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ordaos, Inc.
- CIK
- 1933700
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 228 Park Avenue S
NEW YORK, NY 10003 - Phone
- 201-696-5358
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David Longo · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Ulo Palm · DirectorNew York, NY Find on LinkedIn ↗
-
Benjamin Britt · DirectorNew York, NY Find on LinkedIn ↗
-
James Ramey · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗